Phage therapy for bladder bacteria in spinal cord injury
Treatments studied
Part of Brain & nervous system, Infections, Injuries & trauma, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a special virus (bacteriophage) that attacks E. coli bacteria can help control bacteria in the bladder without causing an infection. It's for people with spinal cord injury who use a catheter and have E. coli in their urine but no active infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older with a spinal cord injury or disease and use a catheter (tube) to empty your bladder.
- You have E. coli bacteria in your urine at a level of 10,000 or more per milliliter, but no symptoms of a bladder infection.
- You are willing to either stay in the hospital for 7 days of treatment or come to the clinic daily (or at least on day 1 and day 7).
- If you could become pregnant, you must use two forms of birth control during the study and for 2 weeks after.
- You do not have a history of organ transplant, neutropenia (low white blood cells), or severe kidney disease (stage 4 or worse).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks patients and caregivers about their experiences with bladder washes (instillations) using lactobacillus or gentamicin to manage urinary symptoms. Your feedback could help improve care for others like you.
This trial tests if giving Botox injections early (within 20 weeks of injury) into the bladder muscle can help with bladder function and prevent problems. It may help people with recent, severe spinal cord injuries above the T6 level.
This trial tests whether specially designed viruses (called phages) can safely and effectively treat drug-resistant urinary tract infections. The phages are delivered directly into your bladder or kidney through a small tube, and the goal is to eliminate the infection when standard antibiotics have failed.
This trial tests a phage (virus that kills bacteria) treatment for women who have had a kidney transplant and keep getting urinary tract infections (UTIs) caused by E. coli bacteria. It aims to see if this therapy can help prevent future infections.
This trial tests if putting a live bacteria called Lactobacillus crispatus into the bladder is safe for people with spinal cord injury and neurogenic lower urinary tract dysfunction. It may help prevent urinary tract infections without antibiotics.
This study tests a treatment using bacteriophages (special viruses that kill bacteria) for infections that happen around metal implants in bones. It aims to see if this approach can safely clear these hard-to-treat infections.
Hear when a new Spinal Cord Injuries trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.